← Database
M&A

SOLIMAR

Acquired by

VIVALTO VIE

SPAIN Health Providers / Healthcare Facilities / Nursing Homes EV 1m EUR - 100m EUR 02/2020

Target

SOLIMAR

Acquirer

VIVALTO VIE

Context

Vivalto Vie acquired 100% of Solimar, a Valencia-based nursing home operator, marking the group's first international expansion outside France. The transaction was executed simultaneously with the closing of the Amundi PEF-led LBO of Vivalto Vie and represents the first building block of the group's Spanish platform, which targets a pipeline of approximately 1,000 additional beds through a combination of further acquisitions and greenfield development projects.

SOLIMAR, which reported an EBITDA margin of LOGIN in 2018, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Healthcare & Pharma sector (13.3x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Solimar is a Spanish nursing home operator based in the Valencia region, operating seven residential care establishments with approximately 930 beds. The group provides residential care services to elderly and dependent people in one of Spain's most populous regions. Solimar represents a well-established local operator in a highly fragmented Spanish nursing home market, which is characterised by strong structural growth dynamics driven by an ageing population and a development stage approximately ten years behind the French market in terms of private sector consolidation.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2018
LOGIN
LOGIN
LOGIN
2017
LOGIN
LOGIN
LOGIN

Other operations with SOLIMAR

REFERENCES

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).